Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Allscripts, iScribe And ePhysician Racing To Put Script Devices In MD Hands

Executive Summary

Allscripts is seeking early market experience in Silicon Valley with its TouchScript hand-held prescribing device.

You may also be interested in...



Allscripts' TouchScript In 400 Practices: $1.3 Mil. From System Sales In 1999

Allscripts' TouchScript hand-held prescribing devices are in use in over 400 physician practice sites six months after its deployment, according to a Feb. 18 prospectus for a 2 mil.-share secondary offering.

Allscripts' TouchScript In 400 Practices: $1.3 Mil. From System Sales In 1999

Allscripts' TouchScript hand-held prescribing devices are in use in over 400 physician practice sites six months after its deployment, according to a Feb. 18 prospectus for a 2 mil.-share secondary offering.

Merck-Medco, Cardinal Support ParkStone Hand-Held Rx Devices

Merck-Medco and Cardinal Health Partners are backing the launch of ParkStone Medical Information Systems' hand-held prescription devices.

Related Content

UsernamePublicRestriction

Register

PS035114

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel